USAID: COVAX Has Raised $6B to Vaccinate 20% of World's Most Vulnerable

The video discusses the global vaccine rollout, highlighting the challenges of inequality between wealthier and poorer nations. It covers the COVAX initiative's efforts to distribute vaccines and the setbacks faced. The US's role in funding and expanding vaccine supply chains is explored, along with the issues of vaccine nationalism and the need for equitable distribution. The video concludes with future plans for expanding vaccine supply and distribution globally.

What is the primary goal of the COVAX initiative?

• To conduct vaccine research

• To expand vaccine availability to poorer countries

• To provide vaccines to wealthier nations

• To develop new vaccines

How much has the US contributed to the COVAX initiative so far?

• $4 billion

• $2 billion

• $1 billion

• $3 billion

What is the Quad initiative's main focus?

• To develop new vaccine technologies

• To provide vaccines to Europe

• To improve vaccine distribution logistics

• To increase vaccine production in India

What is a potential benefit of vaccine surplus in wealthier nations?

• More vaccines for poorer countries

• Delayed vaccine distribution

• Increased vaccine prices

• Reduced vaccine effectiveness

What is the US's stance on sharing vaccines with other countries?

• Share only with European countries

• Share immediately regardless of domestic needs

• Do not share vaccines at all

• Share only after domestic needs are met

What is a major challenge in achieving vaccine equity?

• Excessive vaccine production

• Lack of vaccine research

• Vaccine supply scarcity

• High vaccine costs

What is the relationship between scarcity and equity in vaccine distribution?

• Scarcity is unrelated to equity

• Scarcity has no effect on equity

• Scarcity hinders equity

• Scarcity promotes equity